BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2021973)

  • 1. Synergistic effects of phorbol ester and interferon-alpha: target cell class I HLA antigen expression and resistance to natural killer and lymphokine-activated killer cell-mediated cytolysis.
    Migita K; Eguchi K; Akiguchi I; Ida H; Kawakami A; Ueki Y; Kurata A; Fukuda T; Nagataki S
    Cell Immunol; 1991 May; 134(2):325-35. PubMed ID: 2021973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine NK and LAK susceptibility is independent of class I expression on B lymphoblastoid variants.
    Li W; Splitter GA
    Vet Immunol Immunopathol; 1994 Jun; 41(3-4):189-200. PubMed ID: 7941303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
    Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon--a major regulator of natural killer cell-mediated cytotoxicity.
    Reiter Z
    J Interferon Res; 1993 Aug; 13(4):247-57. PubMed ID: 7693829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
    Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
    J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicity.
    Jabrane-Ferrat N; Calvo F; Faille A; Lagabrielle JF; Boisson N; Quillet A; Fradelizi D
    Br J Cancer; 1990 Apr; 61(4):558-62. PubMed ID: 2109997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms by which HLA-class II molecules protect human B lymphoid tumour cells against NK- and LAK-mediated cytolysis.
    Lobo PI; Chang MY; Mellins E
    Immunology; 1996 Aug; 88(4):625-9. PubMed ID: 8881767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of chronic lymphocytic leukaemia cells to interferon-alpha generated lymphokine activated killer cells.
    Jewell AP; Worman CP; Giles FJ; Goldstone AH; Lydyard PM
    Leuk Lymphoma; 1992 Aug; 7(5-6):473-80. PubMed ID: 1362916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of natural killer cells with MHC class II: reversal of HLA-DR1-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-A.
    Jiang YZ; Couriel D; Mavroudis DA; Lewalle P; Malkovska V; Hensel NF; Dermime S; Molldrem J; Barrett AJ
    Immunology; 1996 Mar; 87(3):481-6. PubMed ID: 8778037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells.
    Naganuma H; Kiessling R; Patarroyo M; Hansson M; Handgretinger R; Grönberg A
    Int J Cancer; 1991 Feb; 47(4):527-32. PubMed ID: 1671670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct effects of interferon-gamma and MHC class I surface antigen levels on resistance of the K562 tumor cell line to natural killer-mediated lysis.
    Maziarz RT; Mentzer SJ; Burakoff SJ; Faller DV
    Cell Immunol; 1990 Oct; 130(2):329-38. PubMed ID: 2119892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol esters potentiate the induction of class I HLA expression by interferon alpha.
    Erusalimsky JD; Kefford RF; Gilmore DJ; Milstein C
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1973-6. PubMed ID: 2494657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity.
    Correale P; Procopio A; Celio L; Caraglia M; Genua G; Coppola V; Pepe S; Normanno N; Vecchio I; Palmieri G
    Cancer Immunol Immunother; 1992; 34(4):272-8. PubMed ID: 1371427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Culture medium induced morphological changes of melanoma cells associated with change in sensitivity to lysis by lymphokine-activated killer cells.
    Perng YP; Lin CC; Perng IM; Shen YC; Chuang CK; Liao SK
    Cancer Biother Radiopharm; 1997 Oct; 12(5):317-31. PubMed ID: 10851482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z
    Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.